Baicalin regulates the dopamine system to control the core symptoms of ADHD
Abstract We aimed to test the therapeutic effects of baicalin on attention deficit hyperactivity disorder (ADHD) in an animal model and to explain the potential mechanism. We investigated the therapeutic effects and mechanisms of baicalin in a spontaneously hypertensive rat (SHR) model of ADHD depen...
Main Authors: | Rongyi Zhou, Jiaojiao Wang, Xinmin Han, Bingxiang Ma, Haixia Yuan, Yuchen Song |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-02-01
|
Series: | Molecular Brain |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13041-019-0428-5 |
Similar Items
-
Memory deficits and hippocampal cytokine expression in a rat model of ADHD
by: Lucy G. Anderson, et al.
Published: (2024-02-01) -
Recent insights into the biological functions of baicalin
by: Priscilla Nadalin, et al.
Published: (2022-08-01) -
Using rodent data to elucidate dopaminergic mechanisms of ADHD: Implications for human personality
by: Gail Tripp, et al.
Published: (2024-01-01) -
D2-like dopamine receptors mediate the response to amphetamine in a mouse model of ADHD
by: Xueliang Fan, et al.
Published: (2007-04-01) -
Activation of PPARγ by baicalin attenuates pulmonary hypertension in an infant rat model by suppressing HMGB1/RAGE signaling
by: Zhenjie Chen, et al.
Published: (2017-04-01)